Logo.PNG
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
03 oct. 2024 03h00 HE | Enara bio
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio’s EDAPT®...
image006.jpg
Radisson annonce l’augmentation de son placement privé préalablement annoncé à 7 millions $
02 oct. 2024 06h30 HE | Ressources Minières Radisson Inc.
ROUYN-NORANDA, Québec, 02 oct. 2024 (GLOBE NEWSWIRE) -- Ressources minières Radisson Inc. (TSX-V : RDS, OTC : RMRDF) (« Radisson » ou la « Société ») est heureuse d’annoncer que due à la forte...
EVOK Logo.jpg
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
01 oct. 2024 08h30 HE | Evoke Pharma, Inc.
Nantahala to nominate 2 board seats Portion of the proceeds received from warrants executed at $8.16/share SOLANA BEACH, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc....
image006.jpg
Radisson annonce l’augmentation de son placement privé préalablement annoncé à 6 millions $
30 sept. 2024 17h18 HE | Ressources Minières Radisson Inc.
ROUYN-NORANDA, Québec, 30 sept. 2024 (GLOBE NEWSWIRE) -- Ressources minières Radisson Inc. (TSX-V : RDS, OTC : RMRDF) (« Radisson » ou la « Société ») est heureuse d’annoncer que due à la forte...
NCAU Banner Logo.png
Newcore Gold Announces Closing of $5.5 Million Private Placement Financings
26 sept. 2024 17h04 HE | Newcore Gold Ltd.
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore"...
HouseAmp and Bosscat Join Forces - logos
HouseAmp Joins Forces with BOSSCAT™ to Offer Seamless Pre-Sell Home Improvement and Integrated Financing Solutions
24 sept. 2024 08h00 HE | HouseAmp Inc.
HouseAmp announced today a new partnership with BOSSCAT™ Home Services and Technologies for real estate brokers and their agents.
R-Rt92-logo-rbg0.png
Route 92 Medical Announces $50 Million Series F Extension Equity Financing
23 sept. 2024 09h00 HE | Route 92 Medical, Inc.
Route 92 Medical announces $50 million series F extension equity financing to support its commercial expansion.
Vaccinex logo
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
18 sept. 2024 08h30 HE | Vaccinex, Inc.
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...